<DOC>
	<DOCNO>NCT02648217</DOCNO>
	<brief_summary>This trial conduct Africa Asia . The aim trial compare efficacy safety insulin degludec/insulin aspart twice daily biphasic insulin aspart twice daily subject type 2 diabetes mellitus , Ramadan .</brief_summary>
	<brief_title>Comparing Efficacy Safety Insulin Degludec/Insulin Aspart Twice Daily Biphasic Insulin Aspart Twice Daily Subjects With Type 2 Diabetes Mellitus Before , During After Ramadan</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Male female , age least 18 year time signing informed consent . Algeria : Male female , age least 19 year time signing informed consent Subjects diagnose ( clinically ) type 2 diabetes mellitus prior day screen ( Visit 1 ) Treated premix/selfmix basal insulin regimen least 90 day prior day screen ( Visit 1 ) Subjects OAD ( ) ( oral antidiabetic drug ) prior trial participation OR subject fix daily dose ( ) OAD ( ) least 90 day prior screen ( Visit 1 ) . The OAD ( ) include follow antidiabetic drug ( ) /regimen : Biguanides ( metformin equal 1500 mg maximum tolerate dose document subject medical record ) Insulin secretagogues ( sulfonylurea ( SU ) glinides ) , Dipeptidyl peptidase4 inhibitor ( DPP4 inhibitor ) , aglucosidase inhibitor , Sodiumglucose cotransporter 2 inhibitor ( SGLT2 Inhibitors ) ( equal half maximum approve dose accord local label maximum tolerate dose document subject medical record ) HbA1c 7.0 % 10.0 % ( 5386 mmol/mol ) ( inclusive , central laboratory analysis ) Intention fast ( daytime , i.e. , dawn sunset ) Ramadan receive medical counsel regard risk fast Willing give blood Ramadan Any contraindication successful sustain fast medical perspective discretion investigator ( acute illness , severe hypoglycaemia within 90 day prior screen ( Visit 1 ) , hypoglycaemia unawareness , ketoacidosis within 90 day prior screen ( Visit ) , hyperosmolar hyperglycaemic coma within 90 day prior screen ( Visit 1 ) , subject perform intense physical labour )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>